Purchase Order 75N91024P00103

Award Date 1/5/24
Potential Completion Date 1/4/25
Potential Value $17K
Ultimate Awardee
Revvity Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $22,515 purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, to provide unspecified services. The single year contract runs from February 20, 2024 through February 19, 2025 and utilizes a firm fixed price payment structure. Performance will occur in Bethesda, Maryland. No additional details were provided regarding the original solicitation...
Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, has been awarded a $22,068 purchase order by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The firm fixed price contract is for maintenance services to be performed between January 1, 2024 and December 31, 2024 at the prime contractor's facility in Hopkinton, Massachusetts. No additional details were provided...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $14,626.20 firm fixed-price purchase order by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract is for maintenance services in support of the agency's research programs, to be performed at the NIH campus in Bethesda, Maryland over a one-year base period ending December 2024. No...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $25,000 purchase order to Revvity Signals Software, Inc. Informatics Division for SOFTWARE. The prime contractor will deliver the requested software products and services over a one-year period of performance from August 1, 2023 through July 31, 2024 under a firm fixed price contract. Revvity Signals Software, Inc. Informatics Division is a subsidiary of Revvity Inc. Medical Imaging, LLC...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,602.20 firm fixed price purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, to provide a service agreement for an Envision Multilabel Plate Reader. The place of performance will be in Rockville, Maryland. The period of performance is one year, from June 30, 2023 through June 29, 2024. As part of its mission to lead the nation in...
Revvity Health Sciences, Inc., a subsidiary of Revvity Inc., has been awarded a firm fixed price purchase order for $15,778.92 to provide maintenance services in support of the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health. The award has no set-aside designation and calls for Revvity Health Sciences to deliver maintenance agreement services with a period of performance through January 11, 2025 at the agency's campus in...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a one-year, firm fixed price purchase order valued at approximately twelve thousand four hundred eighty-six dollars to Revvity Signals Software, Inc. Informatics Division for software. Revvity Signals Software, Inc. Informatics Division is a subsidiary of Revvity Inc. Medical Imaging, LLC Division. No set aside designation or subcontractors were indicated. The National Cancer Institute...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $419,381.68 firm-fixed-price purchase order to Revvity Health Sciences, Inc., a for-profit manufacturer, for a Vectra Polaris Imaging System with 80 slides. The contract, which did not have a set-aside designation, was completed on November 19, 2017. Revvity Health Sciences is an experienced federal contractor that has provided a range of medical devices and laboratory...
This is a firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. The contract is for $4,539.60 and has a period of performance through March 31, 2016. The contract does not have a set-aside designation. Revvity Health Sciences, Inc. is a subsidiary of the parent company Revvity Inc. and provides medical imaging products and services to federal...
This is a $11,447.57 firm fixed price purchase order contract awarded to Revvity Health Sciences, Inc. (a subsidiary of Revvity Inc.) by the National Cancer Institute, a civilian agency under the Department of Health and Human Services. The contract is for the delivery of unspecified "radioactive" items, with a period of performance ending on January 3, 2025. No set-aside designation was utilized. Revvity Health Sciences is a manufacturer of medical imaging products and provider of...

The Department of Health and Human Services' National Institutes of Health's National Cancer Institute awarded a $17,151 purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, to provide unspecified services. The contract has a period of performance from January 5, 2024 through January 4, 2025 and utilizes a firm fixed price contract type. Place of performance will be in Bethesda, Maryland. No additional details regarding scope of work or subcontractors were provided in the award information. The National Cancer Institute conducts and coordinates cancer research across the National Institutes of Health to reduce the burden of cancer and improve outcomes for those diagnosed with the disease.

Generated 12/22/23, 10:58 AM